Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Sarcopenia and knee osteoarthritis (KOA) are common conditions in older adults, but their relationship is controversial. We aimed to examine the potential role of sarcopenia in KOA progression and subsequent knee replacement (KR).

Methods: Using data from the Osteoarthritis Initiative, baseline sarcopenia was first screened according to the EWGSOP2 algorithm using the SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls) questionnaire (screened sarcopenia [Scre-S]), then further assessed combined with the five times chair-stand-test (probable sarcopenia [Prob-S]). Radiographic KOA progression was evaluated by changes in Kellgren-Lawrence Grade and Osteoarthritis Research Society International atlas scores from baseline to the 24- and 48-month follow-ups. Symptomatic progression was evaluated similarly using the Western Ontario McMaster Osteoarthritis Index. The associations of sarcopenia with radiographic or symptomatic progression and subsequent KR were analyzed before and after adjusting for potential confounders and propensity score (PS) matching.

Results: A total of 4,316 participants were included; 27.2% were Scre-S and 16.8% were Prob-S. Baseline Scre-S and Prob-S were positively associated with both radiographic and symptomatic progression in KOA over 24 and 48 months. Both Scre-S and Prob-S were associated with a higher risk of subsequent KR (Scre-S: hazard ratio [HR] 3.84, 95% confidence interval [CI] 3.18 to 4.62; Prob-S: HR 2.29, 95% CI 1.87 to 2.81). These results remained significant in the PS-matched cohort.

Conclusion: Scre-S and Prob-S were significantly and longitudinally associated with both radiographic and symptomatic progression in KOA and subsequent KR. Our findings indicated a potential causal role of sarcopenia in KOA progression and highlighted its potentially therapeutic effect in KOA management.

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.43213DOI Listing

Publication Analysis

Top Keywords

symptomatic progression
16
koa progression
12
radiographic symptomatic
12
scre-s prob-s
12
sarcopenia
8
baseline sarcopenia
8
sarcopenia knee
8
knee osteoarthritis
8
progression
8
knee replacement
8

Similar Publications

c-Jun N-terminal kinases (JNKs), a subfamily of mitogen-activated protein kinases (MAPKs), are key mediators of cellular responses to environmental stress, inflammation, and apoptotic signals. The three isoforms-JNK1, JNK2, and JNK3 exhibit both overlapping and isoform-specific functions. While JNK1 and JNK2 are broadly expressed across tissues and regulate immune signaling, cell proliferation, and apoptosis, JNK3 expression is largely restricted to the brain, heart, and testis, where it plays a crucial role in neuronal function and survival.

View Article and Find Full Text PDF

Salvage treatment of a metastatic colorectal cancer with pMMR/MSS in a 21-year-old man: a case report.

Front Oncol

August 2025

Department of Medical Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.

In metastatic colorectal cancer (mCRC) patients with proficient mismatch repair (pMMR)/microsatellite stability (MSS), beyond third-line therapies were extremely limited. Here, we reported a case of a 21-year-old male patient with pMMR/MSS mCRC who failed to respond to both first- and second-line treatment and subsequently received non-standard third-line therapy at a local hospital. This patient was referred to our hospital, and we initiated salvage therapies.

View Article and Find Full Text PDF

Background: Hypofractionated stereotactic radiotherapy (fSRT) is increasingly used for brain metastases (BMs) from non-small cell lung cancer (NSCLC). However, relevant data concerning treatment outcomes of fSRT and clinical utility of re-irradiation using fSRT (re-fSRT) remain scarce.

Methods: Consecutive NSCLC patients with fSRT-treated BMs from May 2018 to May 2022 were included.

View Article and Find Full Text PDF

Neurodegenerative disorders (NDD) i.e., dementia of the Alzheimer's type, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are a rising worldwide epidemic driven by aging populations and characterized by progressive neuronal impairment.

View Article and Find Full Text PDF

Osteoarthritis (OA) is a multifactorial, mechano-inflammatory joint disorder characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling. Despite its high prevalence and significant impact on quality of life, no disease-modifying treatments have been approved. In many other disease areas, advanced omics technologies are impacting the development of advanced therapies.

View Article and Find Full Text PDF